Authors:
Birindelli, S
Perrone, F
Oggionni, M
Lavarino, C
Pasini, B
Vergani, B
Ranzani, GN
Pierotti, MA
Pilotti, S
Citation: S. Birindelli et al., Rb and TP53 pathway alterations in sporadic and NF1-related malignant peripheral nerve sheath tumors, LAB INV, 81(6), 2001, pp. 833-844
Authors:
Volonterio, A
Bravo, P
Corradi, E
Fronza, G
Meille, SV
Vergani, B
Zanda, M
Citation: A. Volonterio et al., Unusual nonchelation controlled allylation of a N-monoprotected alpha-amino aldehyde: stereoselective entry to nonracemic trifluoromethyl dipeptide isosteres, J FLUORINE, 108(2), 2001, pp. 245-252
Authors:
Pilotti, S
Mezzelani, A
Vergani, B
Minoletti, F
Cristofori, E
Sozzi, G
Pierotti, MA
Citation: S. Pilotti et al., Morphologic-cytogenetic analysis of dedifferentiated liposarcomas with an extensive misleading leiomyosarcomatous component, APPL IMMUNO, 8(3), 2000, pp. 216-221
Authors:
Botti, C
Seregni, E
Menard, S
Collini, P
Tagliabue, E
Campiglio, M
Vergani, B
Ghirelli, C
Aiello, P
Pilotti, S
Bombardieri, E
Citation: C. Botti et al., Two novel monoclonal antibodies against the MUC4 tandem repeat reacting with an antigen overexpressed by lung cancer, INT J B MAR, 15(4), 2000, pp. 312-320
Authors:
Arnone, A
Bravo, P
Frigerio, M
Mele, A
Vergani, B
Viani, F
Citation: A. Arnone et al., Synthesis of enantiomerically pure 2 ',3 ',5 '-trideoxy-4 '-[(diethoxyphosphoryl)difluoromethyl]thymidine analogues, EUR J ORG C, (9), 1999, pp. 2149-2157
Authors:
Mele, A
Vergani, B
Viani, F
Meille, SV
Farina, A
Bravo, P
Citation: A. Mele et al., Experimental evidence for intramolecular attractive nonbonded C-F center dot center dot center dot H-C interactions in 2 ',3 '-dideoxy-4 '-(fluoromethyl)nucleosides - Through-space J(CF) and J(HF) NMR coupling constants, correlation with empirical parameters of solvent polarity and single-crystal X-ray structures, EUR J ORG C, (1), 1999, pp. 187-196
Authors:
Lillo, FB
Ciuffreda, D
Veglia, F
Capiluppi, B
Mastrorilli, E
Vergani, B
Tambussi, G
Lazzarin, A
Citation: Fb. Lillo et al., Viral load and burden modification following early antiretroviral therapy of primary HIV-1 infection, AIDS, 13(7), 1999, pp. 791-796